Będkowska, G.E.; Gacuta, E.; Zbucka-Krętowska, M.; Ławicki, P.; Szmitkowski, M.; Lemancewicz, A.; Motyka, J.; Kobus, A.; Chorąży, M.; Paniczko, M.;
et al. Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer. J. Clin. Med. 2021, 10, 5452.
https://doi.org/10.3390/jcm10225452
AMA Style
Będkowska GE, Gacuta E, Zbucka-Krętowska M, Ławicki P, Szmitkowski M, Lemancewicz A, Motyka J, Kobus A, Chorąży M, Paniczko M,
et al. Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer. Journal of Clinical Medicine. 2021; 10(22):5452.
https://doi.org/10.3390/jcm10225452
Chicago/Turabian Style
Będkowska, Grażyna E., Ewa Gacuta, Monika Zbucka-Krętowska, Paweł Ławicki, Maciej Szmitkowski, Adam Lemancewicz, Joanna Motyka, Agnieszka Kobus, Monika Chorąży, Marlena Paniczko,
and et al. 2021. "Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer" Journal of Clinical Medicine 10, no. 22: 5452.
https://doi.org/10.3390/jcm10225452
APA Style
Będkowska, G. E., Gacuta, E., Zbucka-Krętowska, M., Ławicki, P., Szmitkowski, M., Lemancewicz, A., Motyka, J., Kobus, A., Chorąży, M., Paniczko, M., & Ławicki, S.
(2021). Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer. Journal of Clinical Medicine, 10(22), 5452.
https://doi.org/10.3390/jcm10225452
